Pharsight

Epi E Z Pen Jr patents expiration

EPI E Z PEN JR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7449012 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 11 months from now)

US9586010 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 11 months from now)

US8870827 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 11 months from now)

US7794432 MYLAN SPECIALITY LP Automatic injector with kickback attenuation
Sep, 2025

(1 year, 11 months from now)

US8048035 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 11 months from now)

Epi E Z Pen Jr is owned by Mylan Speciality Lp.

Epi E Z Pen Jr contains Epinephrine.

Epi E Z Pen Jr has a total of 5 drug patents out of which 0 drug patents have expired.

Epi E Z Pen Jr was authorised for market use on 22 December, 1987.

Epi E Z Pen Jr is available in injectable;intramuscular, subcutaneous dosage forms.

The generics of Epi E Z Pen Jr are possible to be released after 11 September, 2025.

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 22 December, 1987

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPI E Z PEN JR before it's drug patent expiration?
More Information on Dosage

EPI E Z PEN JR family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic